Dynamic and Static Approaches to Quantifying 18F-FDG Uptake for Measuring Cancer Response to Therapy, Including the Effect of Granulocyte CSF
暂无分享,去创建一个
Paul E Kinahan | Mark Muzi | David A Mankoff | Brenda F Kurland | Robert K Doot | Paul Kinahan | D. Mankoff | B. Kurland | R. Doot | M. Muzi | L. Peterson | E. Schubert | L. K. Dunnwald | Lanell M Peterson | Erin K Schubert | Lisa K Dunnwald
[1] Fiona J. Gilbert,et al. Monitoring primary breast cancer throughout chemotherapy using FDG-PET , 2007, Breast Cancer Research and Treatment.
[2] R L Wahl,et al. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. , 1993, Radiology.
[3] Robert B Livingston,et al. Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] J. Keyes. SUV: standard uptake or silly useless value? , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] Wolfgang A. Weber,et al. Monitoring chemotherapy and radiotherapy of solid tumors , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[6] Adriaan A. Lammertsma,et al. Measuring [18F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methods , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[7] R. Livingston,et al. Dose-dense anthracycline-based chemotherapy for node-positive breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] C S Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[9] Robert B Livingston,et al. Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] Sung-Cheng Huang,et al. Anatomy of SUV , 2000 .
[11] S C Huang,et al. Anatomy of SUV. Standardized uptake value. , 2000, Nuclear medicine and biology.
[12] Mark Muzi,et al. Quantitative positron emission tomography imaging to measure tumor response to therapy: what is the best method? , 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.
[13] M. Graham,et al. Comparison of simplified quantitative analyses of FDG uptake. , 2000, Nuclear medicine and biology.
[14] G. Peters,et al. Positron emission tomography using 2-deoxy-2-[18F]-fluoro-D-glucose for response monitoring in locally advanced gastroesophageal cancer; a comparison of different analytical methods. , 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.
[15] E. Hoffman,et al. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method , 1979, Annals of neurology.
[16] Joel Karp,et al. Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[17] M Schwaiger,et al. Reproducibility of metabolic measurements in malignant tumors using FDG PET. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] E. DeLong,et al. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.
[19] Mark Muzi,et al. 18F-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[20] Albert Gjedde,et al. Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: A re-examination , 1982, Brain Research Reviews.
[21] E. Hoffman,et al. TOMOGRAPHIC MEASUREMENT OF LOCAL CEREBRAL GLUCOSE METABOLIC RATE IN HUMANS WITH (F‐18)2‐FLUORO-2‐DEOXY-D‐GLUCOSE: VALIDATION OF METHOD , 1980, Annals of neurology.
[22] S. Libutti,et al. Comparison of SUV and Patlak slope for monitoring of cancer therapy using serial PET scans , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[23] Johan Nuyts,et al. Methods to monitor response to chemotherapy in non-small cell lung cancer with 18F-FDG PET. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[24] R. Wahl,et al. Effects of pegfilgrastim on normal biodistribution of 18F-FDG: preclinical and clinical studies. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[25] C. D. Arnett,et al. Glucose Metabolic Rate Kinetic Model Parameter Determination in Humans: The Lumped Constants and Rate Constants for [18F]Fluorodeoxyglucose and [11C]Deoxyglucose , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[26] R. Wahl,et al. Splenic fluorodeoxyglucose uptake increased by granulocyte colony-stimulating factor therapy: PET imaging results. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[27] Adriaan A. Lammertsma,et al. How should we analyse FDG PET studies for monitoring tumour response? , 2006, European Journal of Nuclear Medicine and Molecular Imaging.